Mr. Gerard Rene Grondin, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 14 Laurence Way, Falmouth, ME 04105 Phone: 207-878-8058 |
Dr. Jennifer Horne King, PHD, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 173 Gray Rd, Falmouth, ME 04105 Phone: 207-489-9393 Fax: 207-489-9393 |
Lynn Schardel, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Mackworth Is, Falmouth, ME 04105 Phone: 207-781-6285 |
News Archive
Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.
In response to a European Commission consultation on the EU Clinical Trials Directive, ECCO - the European CanCer Organisation - has supported proposals by its member organisations for adapting the Directive's requirements to reflect practical necessities in cancer research and treatment.
Patients with inflammatory bowel disease are more likely to see dramatic shifts in the make-up of the community of microbes in their gut than healthy people, according to the results of a study published online Feb. 13 in Nature Microbiology.
Armed with $5 bills, the shoppers lined up waiting for the doors to open. Sound like some kind of bizarre sale? This was no sale, it was the scene at the opening of the temporary thrift store at Marriott's University of Maryland University College Inn and Conference Center. Local community members in need were invited to stuff as many clothes as they could into shopping bags for $5 a bag. All proceeds went to the Children's Miracle Network (CMN).
Gilead Sciences, Inc. today announced that the European Commission has granted marketing authorization for Sovaldi (sofosbuvir) 400 mg tablets, a once-daily oral nucleotide analogue polymerase inhibitor for the treatment of chronic hepatitis C infection in adults, in combination with other antiviral agents (ribavirin and pegylated interferon alpha (peg-IFN)).
› Verified 9 days ago